Cardiovascular risk assessment in patients with antiphospholipid syndrome: a cross-sectional performance analysis of nine clinical risk prediction tools

OBJECTIVES: This study aimed to assess the performance of cardiovascular risk (CVR) prediction models reported by European Alliance of Associations for Rheumatology and European Society of Cardiology recommendations to identify high-atherosclerotic CVR (ASCVR) patients with antiphospholipid syndrome...

Descripción completa

Detalles Bibliográficos
Autores principales: Drosos, George C, Konstantonis, George, Sfikakis, Petros P, Tektonidou, Maria G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Autoimmunity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685980/
https://www.ncbi.nlm.nih.gov/pubmed/38016710
http://dx.doi.org/10.1136/rmdopen-2023-003601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685980/
https://www.ncbi.nlm.nih.gov/pubmed/38016710
http://dx.doi.org/10.1136/rmdopen-2023-003601

Ejemplares similares